Medical Device Contract Manufacturing Industry News Update

The report "Medical Device Contract Manufacturing Market by Device (IVD, Drug Delivery, Surgical, Orthopedic Implants), Class of Device (Class I, II, III), and Service (QMS, Process Development, Device & Component Manufacturing, Packaging) – Global Forecast to 2031" The global medical device contract manufacturing market will grow to USD 135.47 billion by 2031 from USD 85.59 billion in 2026, at a CAGR of 9.6% during 2026–2031.

Browse 455 market data Tables and 72 Figures spread through 450 Pages and in-depth TOC on "Medical Device Contract Manufacturing Market by Device (IVD, Drug Delivery, Surgical, Orthopedic Implants), Class of Device (Class I, II, III), and Service (QMS, Process Development, Device & Component Manufacturing, Packaging) – Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-device-contract-manufacturing-market-170622851.html

Medical device manufacturers are increasingly outsourcing assembly, packaging, and processing tasks to specialized partners as demand grows in developing countries. Robotics and automation are boosting production-line output, while Industry 4.0 practices give OEMs better visibility into quality control and delivery processes. The rising demand for home-use and wearable devices is further driving the need for outsourced production. These trends are expected to accelerate as OEMs focus internal resources on design and commercialization.

The IVD devices segment is expected to account for the largest share of the medical device contract manufacturing market during the forecast period.

In 2025, IVD devices held a 19.2% share of the market and are projected to grow at a CAGR of 10.1% from 2026 to 2031. IVD consumables, the disposable components used in in vitro diagnostics (tests conducted outside the living body), offer several advantages that support efficient, accurate medical diagnoses. These diagnostic tests are used in hospitals, laboratories, and homes, resulting in high, repeatable order volumes. IVD manufacturers often outsource the assembly of cartridges, consumables, and instruments to partners equipped with cleanroom capabilities and validated processes. This segment is expected to maintain its leadership through 2031.

The device development & manufacturing services segment is projected to hold the dominant share of the medical device contract manufacturing market throughout the forecast period.

This segment accounted for a 69.1% share in 2025. OEMs typically assign the largest portion of their workload to contract partners for component and finished device production. This is because such production requires specialized tooling, validated processes, and regulated facilities, which OEMs often prefer not to develop themselves. As a result, OEMs are likely to continue engaging partners for comprehensive programs that integrate both development and production.

Asia Pacific is expected to register the highest CAGR in the medical device contract manufacturing market during the forecast period.

The Asia Pacific region is the fastest-growing market, projected to experience a CAGR of 11.0% from 2026 to 2031. This growth is driven by expanding medical device manufacturing capabilities, increased OEM outsourcing, lower manufacturing costs, and rising investments in healthcare infrastructure. China and India are strengthening domestic production capabilities, while Japan remains a key source of demand for advanced, high-quality medical devices. These factors are expected to boost the demand for contract manufacturing services, including design, precision manufacturing, assembly, and other value-added activities.

Key Market Players

The major market players covered in the report include Jabil (US), Flex (US), Plexus (US), Sanmina (US), Integer Holdings (US), TE Connectivity (Switzerland), Celestica (Canada), West Pharmaceutical Services (US), Benchmark Electronics (US), and AptarGroup (US).

Don’t miss out on business opportunities in Medical Device Contract Manufacturing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com